2013
DOI: 10.1097/mnm.0b013e32835c5a24
|View full text |Cite
|
Sign up to set email alerts
|

SPECT/CT in sentinel node imaging

Abstract: Sentinel node lymphoscintigraphy and biopsy has become standard practice for lymphatic staging in early-stage breast cancer and melanoma. More recently, sentinel node lymphoscintigraphy has also been used in head and neck squamous cell cancers and other solid tumours. Single photon emission computed tomography/computed tomography (SPECT/CT) is a new tool and this article reviews its potential application in sentinel node imaging. SPECT/CT provides complementary functional and anatomical information and has bee… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
28
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(32 citation statements)
references
References 49 publications
2
28
0
2
Order By: Relevance
“…These visualization rates are in accordance with the reported 63%-88% for breast cancer (14,16,17), 82%-99% for melanoma (18), and 84%-91% for gynecologic and prostate cancers (6,7,21). SPECT/CT improved the visualization rates to 91.3% for breast cancer, 99.2% for melanoma, and 95.3% for pelvic cancer, again in agreement with the reported rates of 81%-97.3% for breast cancer (16)(17)(18), near 100% for melanoma (18), and 92.2%-100% for gynecologic and prostate cancers (6,7,21,22). SPECT/CT depicted SNs in 3.7% of breast cancer, 0.4% of melanoma, and 4.7% of pelvic cancer patients, respectively, with no SNs visualized on PI, representing a considerable number of patients who would have undergone lymphadenectomy if only PI was performed.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…These visualization rates are in accordance with the reported 63%-88% for breast cancer (14,16,17), 82%-99% for melanoma (18), and 84%-91% for gynecologic and prostate cancers (6,7,21). SPECT/CT improved the visualization rates to 91.3% for breast cancer, 99.2% for melanoma, and 95.3% for pelvic cancer, again in agreement with the reported rates of 81%-97.3% for breast cancer (16)(17)(18), near 100% for melanoma (18), and 92.2%-100% for gynecologic and prostate cancers (6,7,21,22). SPECT/CT depicted SNs in 3.7% of breast cancer, 0.4% of melanoma, and 4.7% of pelvic cancer patients, respectively, with no SNs visualized on PI, representing a considerable number of patients who would have undergone lymphadenectomy if only PI was performed.…”
Section: Discussionsupporting
confidence: 80%
“…Unexpected basin drainage sites and unpredictable pathways also hinder interpretation of planar images. Because of its superior contrast, resolution, and display of exact anatomic landmarks, SPECT/CT can overcome most of these limitations (11)(12)(13)(14)(15)(16)(17)(18).…”
mentioning
confidence: 99%
“…These include improved anatomical localization of sentinel lymph nodes and alteration in the surgical approach, identification of false positive planar findings of hot nodes and better detection rates of sentinel lymph nodes due to better spatial resolution [16]. Valdes et al and other studies also provide similar result [17].…”
Section: Ct In Conjunction With Single Photon Emission Tomography (Spsupporting
confidence: 69%
“…This dual modality provides complementary functional and anatomical information and thus is superior to planar imaging [16]. Images from each modality can be fused or used separately.…”
Section: Ct In Conjunction With Single Photon Emission Tomography (Spmentioning
confidence: 99%
“…Wagner 47 described the benefits of using SPECT/CT in a precise anatomical localization of lymph nodes with a relationship to surrounding anatomical structures. He confirmed the identification of additional lymph nodes that were not visible on a planar scan and highlighted the reduction of potential artefacts (a skin contamination) or technical difficulties after application of the radiopharmaceutical.…”
Section: Spect/ct Improve the Localization Of Displayed Lymph Nodesmentioning
confidence: 99%